SEC Tracker
Get the app

Brooklyn ImmunoTherapeutics ERNA

Brooklyn ImmunoTherapeutics Completes Acquisition of Novellus Therapeutics

Form
8-K
Filed
Period
Importance
Major
Document
8-K
Exhibit 10.1
Material contract
Exhibit 10.2
Material contract
Exhibit 99.1
Press release
  • Signs a material agreement (1.01)
  • Completes an acquisition or sale of assets (2.01)
  • Sells unregistered shares (3.02)
  • Makes a Regulation FD disclosure (7.01)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Brooklyn ImmunoTherapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Marker Therapeutics MRKR public float $17M, Jun 30, 2025
  2. Charlie's Holdings CHUC public float $18M, Jun 30, 2025
  3. Cognition Therapeutics CGTX public float $18M, Jun 30, 2025
  4. IGC Pharma IGC public float $18M, Jun 30, 2025
  5. Lipocine LPCN public float $16M, Jun 30, 2025